These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32525055)

  • 21. Metformin use reduced the overall risk of cancer in diabetic patients: A study based on the Korean NHIS-HEALS cohort.
    Kim YS; Choi EA; Lee JW; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kang HT; Kim J
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1714-1722. PubMed ID: 32753274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy.
    McAlister FA; Eurich DT; Majumdar SR; Johnson JA
    Eur J Heart Fail; 2008 Jul; 10(7):703-8. PubMed ID: 18571471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pharmacist's perspective on metformin use and cancer outcomes.
    Ceacareanu AC
    J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients.
    Singh Y; Gupta G; Anand K; Kumar Jha N; Thangavelu L; Kumar Chellappan D; Dua K
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):580-582. PubMed ID: 33577009
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study.
    Grégoire JP; Sirois C; Blanc G; Poirier P; Moisan J
    Value Health; 2010; 13(6):820-8. PubMed ID: 21054658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic Benefit of Statin and Metformin in Gastrointestinal Malignancies.
    Nimako GK; Wintrob ZA; Sulik DA; Donato JL; Ceacareanu AC
    J Pharm Pract; 2017 Apr; 30(2):185-194. PubMed ID: 26811340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin vs sulfonylureas for second-line diabetes treatment.
    Roumie CL; Greevy RA; Griffin MR
    JAMA; 2014 Oct 22-29; 312(16):1694. PubMed ID: 25335156
    [No Abstract]   [Full Text] [Related]  

  • 28. Preliminary trial of a powerful new sulphonylurea in maturity-onset diabetes--HB419 (glibenclamide).
    Jackson WP; Vinik AI
    S Afr Med J; 1969 Aug; 43(32):1002-4. PubMed ID: 4898090
    [No Abstract]   [Full Text] [Related]  

  • 29. Genital defects seen in sons of men taking major diabetes drug.
    Wadman M
    Science; 2022 Apr; 376(6588):16-17. PubMed ID: 35357930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin stinks, literally.
    Pelletier AL; Butler AM; Gillies RA; May JR
    Ann Intern Med; 2010 Feb; 152(4):267-8. PubMed ID: 20157150
    [No Abstract]   [Full Text] [Related]  

  • 31. An oncologist's perspective on metformin use and acute lymphoblastic leukemia outcomes.
    Wang ES; Wetzler M
    J Pharm Pract; 2015 Feb; 28(1):46-7. PubMed ID: 25715082
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term efficacy of metformin therapy in nonobese individuals with type 2 diabetes.
    Ong CR; Molyneaux LM; Constantino MI; Twigg SM; Yue DK
    Diabetes Care; 2006 Nov; 29(11):2361-4. PubMed ID: 17065668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescription patterns for diabetes mellitus and therapeutic implications: a population-based analysis.
    Guidoni CM; Borges AP; Freitas Od; Pereira LR
    Arq Bras Endocrinol Metabol; 2012 Mar; 56(2):120-7. PubMed ID: 22584565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin in breast cancer: time for action.
    Goodwin PJ; Ligibel JA; Stambolic V
    J Clin Oncol; 2009 Jul; 27(20):3271-3. PubMed ID: 19487373
    [No Abstract]   [Full Text] [Related]  

  • 35. Metformin: Potential analgesic?
    Smith B; Ang D
    Pain Med; 2015 Dec; 16(12):2256-60. PubMed ID: 26031427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Aquilante CL; Zhang W; McCollum M
    Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment with oral antidiabetics].
    Tidsskr Nor Laegeforen; 1971 Aug; 91(21):1555-8. PubMed ID: 5569818
    [No Abstract]   [Full Text] [Related]  

  • 38. Oral hypoglycemic agents in pregnancy.
    Refuerzo JS
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):227-34, ix. PubMed ID: 21575798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.
    Chan CW; Yu CL; Lin JC; Hsieh YC; Lin CC; Hung CY; Li CH; Liao YC; Lo CP; Huang JL; Lin CH; Wu TJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):20. PubMed ID: 29368615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HB419 (glibenclamide) in the treatment of diabetes mellitus.
    Schneider T; Lopis S
    S Afr Med J; 1969 Aug; 43(32):981-3. PubMed ID: 4898344
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.